ASX - By Stock
|
BNL |
Re:
Ann: State 16 Intermediate Hole Section Drilled
|
|
Bpharma
|
24 |
5.0K |
4 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
24
|
5.0K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Approval to Start Phase I/II Diabetic Foot Ulcer Study
|
|
Bpharma
|
29 |
9.6K |
1 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
29
|
9.6K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Approval to Start Phase I/II Diabetic Foot Ulcer Study
|
|
Bpharma
|
29 |
9.6K |
1 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
29
|
9.6K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Approval to Start Phase I/II Diabetic Foot Ulcer Study
|
|
Bpharma
|
29 |
9.6K |
5 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
29
|
9.6K
|
5
|
|
ASX - By Stock
|
CND |
Re:
Woooooo Hoooooo Go CND :)$$$$$
|
|
Bpharma
|
40 |
11K |
4 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
40
|
11K
|
4
|
|
ASX - By Stock
|
CND |
Re:
Woooooo Hoooooo Go CND :)$$$$$
|
|
Bpharma
|
40 |
11K |
2 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
40
|
11K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
Bpharma
|
51 |
19K |
3 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
51
|
19K
|
3
|
|
ASX - By Stock
|
LMG |
Re:
Ann: Magnesium Oxide Production
|
|
Bpharma
|
47 |
17K |
1 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
47
|
17K
|
1
|
|
ASX - By Stock
|
PVE |
Re:
Ann: Change of Director's Interest Notice
|
|
Bpharma
|
7 |
1.6K |
1 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
7
|
1.6K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: MCRI Pilot Study- Positive Efficacy Data for Lung Infections
|
|
Bpharma
|
19 |
5.0K |
1 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
19
|
5.0K
|
1
|
|
ASX - By Stock
|
CND |
Re:
CND chart
|
|
Bpharma
|
2 |
704 |
0 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
2
|
704
|
0
|
|
ASX - By Stock
|
CND |
Re:
Woooooo Hoooooo Go CND :)$$$$$
|
|
Bpharma
|
40 |
11K |
1 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
40
|
11K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: MCRI Pilot Study- Positive Efficacy Data for Lung Infections
|
|
Bpharma
|
19 |
5.0K |
2 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
19
|
5.0K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
Bpharma
|
51 |
19K |
0 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
51
|
19K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: MCRI Pilot Study- Positive Efficacy Data for Lung Infections
|
|
Bpharma
|
19 |
5.0K |
6 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
19
|
5.0K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: China Patent Granted for RECCE Anti-Infectives
|
|
Bpharma
|
7 |
1.9K |
5 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
7
|
1.9K
|
5
|
|
ASX - By Stock
|
LMG |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Bpharma
|
39 |
13K |
4 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
39
|
13K
|
4
|
|
ASX - By Stock
|
CND |
Re:
Woooooo Hoooooo Go CND :)$$$$$
|
|
Bpharma
|
40 |
11K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
40
|
11K
|
1
|
|
ASX - By Stock
|
GLN |
Re:
Ann: Quarterly Activities and Cash Flow Report
|
|
Bpharma
|
214 |
60K |
0 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
214
|
60K
|
0
|
|
ASX - By Stock
|
GLN |
Re:
Ann: Quarterly Activities and Cash Flow Report
|
|
Bpharma
|
214 |
60K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
214
|
60K
|
1
|
|
ASX - By Stock
|
GLN |
Re:
Ann: Quarterly Activities and Cash Flow Report
|
|
Bpharma
|
214 |
60K |
2 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
214
|
60K
|
2
|
|
ASX - By Stock
|
GLN |
Re:
Ann: Quarterly Activities and Cash Flow Report
|
|
Bpharma
|
214 |
60K |
5 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
214
|
60K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
[INTERVIEW] Recce gearing up for Indonesian trials
|
|
Bpharma
|
47 |
14K |
24 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
47
|
14K
|
24
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Options Prospectus
|
|
Bpharma
|
16 |
5.7K |
0 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
16
|
5.7K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
Bpharma
|
51 |
19K |
10 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
51
|
19K
|
10
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
Bpharma
|
51 |
19K |
9 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
19K
|
9
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
Bpharma
|
51 |
19K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
19K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
Bpharma
|
51 |
19K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
51
|
19K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
Bpharma
|
51 |
19K |
11 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
51
|
19K
|
11
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
Bpharma
|
51 |
19K |
4 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
51
|
19K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Bpharma
|
4 |
2.1K |
7 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
4
|
2.1K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
Bpharma
|
51 |
19K |
7 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
51
|
19K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
Bpharma
|
51 |
19K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
51
|
19K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
Bpharma
|
51 |
19K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
51
|
19K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
Bpharma
|
51 |
19K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
51
|
19K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP
|
|
Bpharma
|
51 |
19K |
10 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
51
|
19K
|
10
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Annual Report to shareholders
|
|
Bpharma
|
36 |
10K |
4 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
36
|
10K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
[INTERVIEW] Recce gearing up for Indonesian trials
|
|
Bpharma
|
47 |
14K |
6 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
47
|
14K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Pharmaceuticals - Business Update
|
|
Bpharma
|
22 |
8.4K |
9 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
22
|
8.4K
|
9
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Pharmaceuticals - Business Update
|
|
Bpharma
|
22 |
8.4K |
5 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
22
|
8.4K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Pharmaceuticals - Business Update
|
|
Bpharma
|
22 |
8.4K |
20 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
22
|
8.4K
|
20
|
|
ASX - By Stock
|
CND |
Re:
Woooooo Hoooooo go GLV :)$$&&&
|
|
Bpharma
|
191 |
55K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
191
|
55K
|
0
|
|
ASX - By Stock
|
LMG |
Re:
general discussion
|
|
Bpharma
|
2.0K |
882K |
0 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
2.0K
|
882K
|
0
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Update on BBB 33 Evaluation and Bolling 4 Drilling
|
|
Bpharma
|
220 |
79K |
0 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
220
|
79K
|
0
|
|
ASX - By Stock
|
CND |
Re:
Ann: Additional deeper targets identified in Bonito Prospect
|
|
Bpharma
|
47 |
11K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
47
|
11K
|
2
|
|
ASX - By Stock
|
CND |
Re:
Woooooo Hoooooo go GLV :)$$&&&
|
|
Bpharma
|
191 |
55K |
4 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
191
|
55K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
Bpharma
|
48 |
15K |
2 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
48
|
15K
|
2
|
|
ASX - By Stock
|
CND |
Re:
Woooooo Hoooooo go GLV :)$$&&&
|
|
Bpharma
|
191 |
55K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
191
|
55K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
Bpharma
|
48 |
15K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
48
|
15K
|
1
|
|
ASX - By Stock
|
CND |
Re:
Woooooo Hoooooo go GLV :)$$&&&
|
|
Bpharma
|
191 |
55K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
191
|
55K
|
1
|
|